Atea Pharmaceuticals to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
Yahoo Finance · Sep 8, 2026 · Atea Pharmaceuticals Inc (AVIR)
BOSTON, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a late-stage clinical biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced that Jean-Pierre Sommadossi, PhD, Chief Executive Officer and Founder of Atea, together with other members of the Atea management team, will present at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, Septembe
Not investment advice. Headline and summary only, not a full reprint.